Whalesbook
Vivanza Biosciences Ltd announced that Mr. Chaitra Arora has resigned from his positions as Company Secretary, Compliance Officer, and Key Managerial Personnel (KMP). His resignation is effective from the close of business hours on April 30, 2026. The company indicated that Mr. Arora is leaving to pursue external career opportunities, with no other material reasons cited for his departure.
The departure of a Company Secretary and Compliance Officer is significant, given the role's importance in ensuring regulatory adherence and corporate governance. Vivanza Biosciences will need to appoint a successor promptly to maintain operational continuity and compliance standards.
This is not the first recent change in the company's compliance leadership. Ms. Siddhi Shah previously resigned as Company Secretary & Compliance Officer effective September 26, 2025, following Mr. Avinash Bhojwani's resignation from the same post on February 28, 2025. Mr. Arora himself was appointed to the role on November 11, 2025.
With a critical KMP role now vacant, Vivanza Biosciences must initiate a search for a suitable replacement. Shareholders will be looking for continuity in governance and compliance, and the speed of appointing a new Company Secretary will be key to the effectiveness of this transition.
Investors may watch for signs of instability or challenges in retaining key compliance personnel, given the recent churn in this specific role.
The company, which has a paid-up share capital of Rs. 4 crore and net worth of Rs. 4,02,03,752.40 as of April 14, 2026, qualifies for certain regulatory exemptions due to its size.
Key next steps for the company include appointing a new Company Secretary & Compliance Officer, implementing succession planning for key roles, and ensuring continued adherence to SEBI regulations.